bioRxivPathologyPreprint
C1q/CTRP1 exerts neuroprotective effects in TBI rats by regulating inflammation and autophagy
M. Pei, C. Wang, Z. Li, J. Zhang, P. Huang, J. Wang, J. Huang, D. Zou, Y. Chen
Abstract
ObjectiveC1q/CTRP1 is a newly discovered adiponectin protein, which is highly expressed in adipose and heart tissues. Recent studies have revealed that C1q/CTRP1 can regulate metabolism and inhibit inflammation. CTRP1 is also expressed in brain tissues and vascular cells of human and rat, and research on cerebral hemorrhage and cerebral ischemia-reperfusion injury demonstrates that the CTRP family can attenuate secondary brain injury and exert neuroprotective effects. Thus, this study was designed to explore the role of CTRP1 in traumatic brain injury (TBI) and the underlying mechanism. Main methodsRats were assigned into rCTRP1 group, vehicle group, and sham group. Modified Feeneys method was used to establish a closed traumatic brain injury model. Morris water maze was used for directional navigation, reverse searching and space exploration tests in rats. In addition, Golgi-Cox staining was utilized to visualize neurons, dendrites and dendritic spines. ELISA was conducted to detect the levels of inflammatory factors (IL-6 and TNF-). Finally, Western blot was adopted to detect the relative expression of p-mTOR and autophagy-related proteins (Beclin-1 and LC3-II). ResultsCTRP1 improved the behavioral and histopathological outcomes, inhibited the inflammatory response, activated mTOR and decreased autophagy-associated protein synthesis in TBI rats. ConclusionCTRP1 exerts neuroprotective effects in TBI rats by regulating inflammation and autophagy and has potential therapeutic properties after TBI.
- organism: rat
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- C-terminal binding proteins 1 and 2 in traumatic brain injury-induced inflammation and their inhibition as an approach for anti-inflammatory treatment
Hong Li, Caiguo Zhang, … Mingxia Huang·International Journal of Biological SciencesPeer-reviewed·Jan 1, 2020
- Complement factor C1q mediates chronic neuron loss and inflammation post-brain injury
Stephanie S. Holden, Fiorella Carla Grandi, … Jeanne T. Paz·SciencePeer-reviewed·Sep 9, 2021
- A neuroprotective tetrapeptide for treatment of acute traumatic brain injury
Aman P. Mann, Sazid Hussain, … Erkki Ruoslahti·EMBO Molecular MedicinePeer-reviewed·Oct 1, 2025
- Impact of innate immune activation on T cell dynamics and functional recovery following traumatic brain injury
Sahil Threja, Nathan Ryzewski Strogulski, … David J. Loane·bioRxiv·Mar 26, 2026
- PD-L1-expressing astrocytes act as a gate-keeper for neuroinflammation in the central nervous system of mice with traumatic brain injury
- N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice
Chinmoy Sarkar, Nivedita Hegdekar, Marta M. Lipinski·bioRxiv·Sep 8, 2019